Garsorasib is a pharmaceutical compound used as a selective inhibitor of the KRAS G12C-mutant enzyme for cancer research. It is supplied as an active pharmaceutical ingredient for use in drug manufacturing and research applications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2559761-14-5
Belotecan
pharmaceutical raw material
Example 8
pharmaceutical raw material
Sodium sulfapyridazine
pharmaceutical raw material
Zucapsaicin
pharmaceutical raw material
7-(2-amino-6-fluorophenyl)-1-(4,6-dicyclopropylpyrimidin-5-yl)-4-[(2S,5R)-2,5-dimethyl-4-prop-2-enoylpiperazin-1-yl]-6-fluoropyrido[2,3-d]pyrimidin-2-one
DKFRWZJCNPETGI-SJORKVTESA-N
C[C@@H]1CN([C@H](CN1C(=O)C=C)C)C2=NC(=O)N(C3=NC(=C(C=C32)F)C4=C(C=CC=C4F)N)C5=C(N=CN=C5C6CC6)C7CC7